Thermo Fisher Scientific Inc.
TMO· NYSE
TMOThermo Fisher Scientific Inc.
Filed Feb 24, 2022 · 10-K · 55 days after period end · 0000097745-22-000011
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $10.70B | $10.55B | $6.83B | $6.51B |
| Net Income | $1.66B | — | — | — |
| EPS Diluted | — | — | $2.49 | $2.22 |
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2021 · filed Feb 24, 2022 · 55 d after period end
